SETDB1 is a new promising target in HCC therapy.

Chin Clin Oncol

Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.

Published: December 2016

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2016.05.04DOI Listing

Publication Analysis

Top Keywords

setdb1 promising
4
promising target
4
target hcc
4
hcc therapy
4
setdb1
1
target
1
hcc
1
therapy
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!